Medicines in development

Our compounds in development target various stages of the HIV lifecycle.

Binding and fusion

Product: VH3810109A
Class: bnAb
Phase: II
Reverse transcription
Nuclear entry & uncoating

Product: VH400280
Class: Capsid Inhibitor
Phase: I
Integration

Product: Cabotegravir400
Class: INSTI
Phase: I

Product: VH4524184
Class: INSTI
Phase: Pre-Clinical
Transcription/translation
Assembly and budding

Product: VH401499
Class: Capsid Inhibitor
Phase: Pre-clinical
Maturation

Product: GSK3640254
Class: Maturation Inhibitor
Phase: II

Product: GSK3739937
Class: Maturation Inhibitor
Phase: I

NP-GBL-HVX-WCNT-220012 April 2022

ViiV Healthcare
980 Great West Road
Brentford
Middlesex
TW8 9GS
UK

Tel. +44 (0)20 8380 6200

ViiV Healthcare

Report an adverse event

NP-GBL-HVX-WCNT-220005 April 2022

This is a medical information resource for healthcare professionals only. Information provided within this side has been approved to UK regulations and may be subject to different medical and regulatory requirements in other countries. It is important to follow local laws and regulations when prescribing medicines.